TreeWAS – Variant ID: rs2912522

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.000	1.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.000	0.483	0.517
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.000	0.613	0.386
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.000	0.629	0.370
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.000	0.629	0.370
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.000	0.629	0.370
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.000	0.629	0.370
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.000	0.629	0.370
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.000	0.629	0.370
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.000	0.629	0.370
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.000	0.629	0.370
M72 Fibroblastic disorders	0.001	0.871	0.127
M72.9 Fibroblastic disorder, unspecified	0.001	0.908	0.091
M72.8 Other fibroblastic disorders	0.001	0.908	0.091
M72.6 Necrotizing fasciitis	0.001	0.908	0.091
M72.4 Pseudosarcomatous fibromatosis	0.001	0.908	0.091
M72.3 Nodular fasciitis	0.001	0.908	0.091
M72.5 Fasciitis, not elsewhere classified	0.001	0.914	0.085
M72.1 Knuckle pads	0.001	0.917	0.082
M72.2 Plantar fascial fibromatosis	0.001	0.924	0.075
M72.39 Nodular fasciitis-Site unspec	0.001	0.933	0.066
M72.38 Nodular fasciitis-Other	0.001	0.933	0.066
M72.37 Nodular fasciitis-Ankle/Foot	0.001	0.933	0.066
M72.36 Nodular fasciitis-Lower Leg	0.001	0.933	0.066
M72.35 Nodular fasciitis-Pelvic/Thigh	0.001	0.933	0.066
M72.34 Nodular fasciitis-Hand	0.001	0.933	0.066
M72.33 Nodular fasciitis-Forearm	0.001	0.933	0.066
M72.32 Nodular fasciitis-Upper arm	0.001	0.933	0.066
M72.31 Nodular fasciitis-Shldr region	0.001	0.933	0.066
M72.30 Nodular fasciitis-Mult sites	0.001	0.933	0.066
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)	0.001	0.933	0.066
M72.48 Pseudosarcomatous fibromatosis (Other)	0.001	0.933	0.066
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)	0.001	0.933	0.066
M72.46 Pseudosarcomatous fibromatosis (Lower leg)	0.001	0.933	0.066
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)	0.001	0.933	0.066
M72.44 Pseudosarcomatous fibromatosis (Hand)	0.001	0.933	0.066
M72.43 Pseudosarcomatous fibromatosis (Forearm)	0.001	0.933	0.066
M72.42 Pseudosarcomatous fibromatosis (Upper arm)	0.001	0.933	0.066
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)	0.001	0.933	0.066
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)	0.001	0.933	0.066
M72.69 Necrotizing fasciitis (Site unspecified)	0.001	0.933	0.066
M72.68 Necrotizing fasciitis (Other)	0.001	0.933	0.066
M72.67 Necrotizing fasciitis (Ankle and foot)	0.001	0.933	0.066
M72.66 Necrotizing fasciitis (Lower leg)	0.001	0.933	0.066
M72.65 Necrotizing fasciitis (Pelvic region and thigh)	0.001	0.933	0.066
M72.64 Necrotizing fasciitis (Hand)	0.001	0.933	0.066
M72.63 Necrotizing fasciitis (Forearm)	0.001	0.933	0.066
M72.62 Necrotizing fasciitis (Upper arm)	0.001	0.933	0.066
M72.61 Necrotizing fasciitis (Shoulder region)	0.001	0.933	0.066
M72.60 Necrotizing fasciitis (Multiple sites)	0.001	0.933	0.066
M72.89 Other fibroblastic disorders (Site unspecified)	0.001	0.933	0.066
M72.88 Other fibroblastic disorders (Other)	0.001	0.933	0.066
M72.87 Other fibroblastic disorders (Ankle and foot)	0.001	0.933	0.066
M72.86 Other fibroblastic disorders (Lower leg)	0.001	0.933	0.066
M72.85 Other fibroblastic disorders (Pelvic region and thigh)	0.001	0.933	0.066
M72.84 Other fibroblastic disorders (Hand)	0.001	0.933	0.066
M72.83 Other fibroblastic disorders (Forearm)	0.001	0.933	0.066
M72.82 Other fibroblastic disorders (Upper arm)	0.001	0.933	0.066
M72.81 Other fibroblastic disorders (Shoulder region)	0.001	0.933	0.066
M72.80 Other fibroblastic disorders (Multiple sites)	0.001	0.933	0.066
M72.99 Fibroblastic disorder, unspecified (Site unspecified)	0.001	0.933	0.066
M72.98 Fibroblastic disorder, unspecified (Other)	0.001	0.933	0.066
M72.97 Fibroblastic disorder, unspecified (Ankle and foot)	0.001	0.933	0.066
M72.96 Fibroblastic disorder, unspecified (Lower leg)	0.001	0.933	0.066
M72.95 Fibroblastic disorder, unspecified (Pelvic region and thigh)	0.001	0.933	0.066
M72.94 Fibroblastic disorder, unspecified (Hand)	0.001	0.933	0.066
M72.93 Fibroblastic disorder, unspecified (Forearm)	0.001	0.933	0.066
M72.92 Fibroblastic disorder, unspecified (Upper arm)	0.001	0.933	0.066
M72.91 Fibroblastic disorder, unspecified (Shoulder region)	0.001	0.933	0.066
M72.90 Fibroblastic disorder, unspecified (Multiple sites)	0.001	0.933	0.066
M72.59 Fasciitis, not elsewhere classified-Site unspec	0.001	0.938	0.061
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot	0.001	0.938	0.061
M72.56 Fasciitis, not elsewhere classified-Lower Leg	0.001	0.938	0.061
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh	0.001	0.938	0.061
M72.54 Fasciitis, not elsewhere classified-Hand	0.001	0.938	0.061
M72.53 Fasciitis, not elsewhere classified-Forearm	0.001	0.938	0.061
M72.52 Fasciitis, not elsewhere classified-Upper arm	0.001	0.938	0.061
M72.51 Fasciitis, not elsewhere classified-Shldr region	0.001	0.938	0.061
M72.50 Fasciitis, not elsewhere classified-Mult sites	0.001	0.938	0.061
M72.19 Knuckle pads (Site unspecified)	0.001	0.940	0.059
M72.18 Knuckle pads-Other	0.001	0.940	0.059
M72.17 Knuckle pads (Ankle and foot)	0.001	0.940	0.059
M72.16 Knuckle pads-Lower Leg	0.001	0.940	0.059
M72.15 Knuckle pads-Pelvic/Thigh	0.001	0.940	0.059
M72.13 Knuckle pads-Forearm	0.001	0.940	0.059
M72.12 Knuckle pads-Upper arm	0.001	0.940	0.059
M72.11 Knuckle pads-Shldr region	0.001	0.940	0.059
M72.10 Knuckle pads (Multiple sites)	0.001	0.940	0.059
M72.58 Fasciitis, not elsewhere classified-Other	0.001	0.945	0.054
M72.28 Plantar fascial fibromatosis-Other	0.001	0.946	0.054
M72.26 Plantar fascial fibromatosis-Lower Leg	0.001	0.946	0.054
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.001	0.946	0.054
M72.24 Plantar fascial fibromatosis-Hand	0.001	0.946	0.054
M72.23 Plantar fascial fibromatosis-Forearm	0.001	0.946	0.054
M72.22 Plantar fascial fibromatosis-Upper arm	0.001	0.946	0.054
M72.21 Plantar fascial fibromatosis-Shldr region	0.001	0.946	0.054
M72.20 Plantar fascial fibromatosis-Mult sites	0.001	0.946	0.054
M72.29 Plantar fascial fibromatosis-Site unspec	0.001	0.947	0.052
M72.14 Knuckle pads (Hand)	0.001	0.950	0.049
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.001	0.960	0.039
G50.0 Trigeminal neuralgia	0.014	0.986	0.000
M79.19 Myalgia (Site unspecified)	0.011	0.989	0.000
M79.1 Myalgia	0.011	0.989	0.000
M79.18 Myalgia (Other)	0.010	0.990	0.000
M79.16 Myalgia (Lower leg)	0.010	0.990	0.000
M79.10 Myalgia (Multiple sites)	0.009	0.991	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.991	0.009
M79.11 Myalgia (Shoulder region)	0.008	0.992	0.000
M79.17 Myalgia (Ankle and foot)	0.008	0.992	0.000
M79.14 Myalgia (Hand)	0.008	0.992	0.000
M79.13 Myalgia (Forearm)	0.008	0.992	0.000
M79.12 Myalgia (Upper arm)	0.008	0.992	0.000
M79.0 Rheumatism, unspecified	0.008	0.992	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.008	0.992	0.000
M79 Other soft tissue disorders, not elsewhere classified	0.008	0.992	0.000
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.008	0.992	0.000
M79.15 Myalgia (Pelvic region and thigh)	0.007	0.992	0.000
H34.8 Other retinal vascular occlusions	0.000	0.993	0.007
M79.09 Rheumatism, unspecified (Site unspecified)	0.007	0.993	0.000
C44.0 Skin of lip	0.007	0.993	0.000
Y43.3 Other antineoplastic drugs	0.007	0.993	0.000
M79.08 Rheumatism, unspecified (Other)	0.007	0.993	0.000
M79.7 Fibromyalgia	0.007	0.993	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.007	0.993	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.006	0.994	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.006	0.994	0.000
M79.8 Other specified soft tissue disorders	0.006	0.994	0.000
H72 Perforation of tympanic membrane	0.000	0.994	0.006
Y43 Primarily systemic agents	0.006	0.994	0.000
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.994	0.006
M79.2 Neuralgia and neuritis, unspecified	0.006	0.994	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.006	0.994	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.006	0.994	0.000
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.006	0.994	0.000
M79.04 Rheumatism, unspecified (Hand)	0.006	0.994	0.000
M79.03 Rheumatism, unspecified (Forearm)	0.006	0.994	0.000
M79.02 Rheumatism, unspecified (Upper arm)	0.006	0.994	0.000
N75.1 Abscess of Bartholin's gland	0.000	0.994	0.006
G50 Disorders of trigeminal nerve	0.006	0.994	0.000
M79.79 Fibromyalgia (Site unspecified)	0.006	0.994	0.000
M79.3 Panniculitis, unspecified	0.006	0.994	0.000
H72.2 Other marginal perforations of tympanic membrane	0.000	0.994	0.006
M79.9 Soft tissue disorder, unspecified	0.005	0.994	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.995	0.005
M79.5 Residual foreign body in soft tissue	0.005	0.995	0.000
M79.88 Other specified soft tissue disorders (Other)	0.005	0.995	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.995	0.005
M79.70 Fibromyalgia (Multiple sites)	0.005	0.995	0.000
M79.4 Hypertrophy of (infrapatellar) fat pad	0.005	0.995	0.000
M79.28 Neuralgia and neuritis, unspecified (Other)	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)	0.005	0.995	0.000
K59.1 Functional diarrhoea	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
M79.82 Other specified soft tissue disorders (Upper arm)	0.005	0.995	0.000
Y54.3 Benzothiadiazine derivatives	0.005	0.995	0.000
M79.27 Neuralgia and neuritis, unspecified (Ankle and foot)	0.005	0.995	0.000
M79.78 Fibromyalgia (Other)	0.005	0.995	0.000
M79.77 Fibromyalgia (Ankle and foot)	0.005	0.995	0.000
M79.76 Fibromyalgia (Lower leg)	0.005	0.995	0.000
M79.75 Fibromyalgia (Pelvic region and thigh)	0.005	0.995	0.000
M79.74 Fibromyalgia (Hand)	0.005	0.995	0.000
M79.73 Fibromyalgia (Forearm)	0.005	0.995	0.000
M79.72 Fibromyalgia (Upper arm)	0.005	0.995	0.000
M79.71 Fibromyalgia (Shoulder region)	0.005	0.995	0.000
Y43.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.995	0.005
D73.0 Hyposplenism	0.000	0.995	0.005
Y40.0 Penicillins	0.005	0.995	0.000
M79.23 Neuralgia and neuritis, unspecified (Forearm)	0.005	0.995	0.000
Q27.3 Peripheral arteriovenous malformation	0.005	0.995	0.000
Y43.4 Immunosuppressive agents	0.005	0.995	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.005	0.995	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.005	0.995	0.000
M79.94 Soft tissue disorder, unspecified (Hand)	0.005	0.995	0.000
G63.2 Diabetic polyneuropathy	0.000	0.995	0.005
Y43.1 Antineoplastic antimetabolites	0.005	0.995	0.000
M79.58 Residual foreign body in soft tissue (Other)	0.005	0.995	0.000
G50.8 Other disorders of trigeminal nerve	0.005	0.995	0.000
Y43.9 Primarily systemic agent, unspecified	0.005	0.995	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.005	0.995	0.000
Y43.6 Enzymes, not elsewhere classified	0.005	0.995	0.000
Y43.5 Acidifying and alkalising agents	0.005	0.995	0.000
Y43.2 Antineoplastic natural products	0.005	0.995	0.000
G50.9 Disorder of trigeminal nerve, unspecified	0.005	0.995	0.000
M79.24 Neuralgia and neuritis, unspecified (Hand)	0.005	0.995	0.000
M79.22 Neuralgia and neuritis, unspecified (Upper arm)	0.005	0.995	0.000
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)	0.005	0.995	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.005	0.995	0.000
Y41.5 Antiviral drugs	0.004	0.995	0.000
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)	0.004	0.995	0.000
M79.97 Soft tissue disorder, unspecified (Ankle and foot)	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
M79.39 Panniculitis, unspecified (Site unspecified)	0.004	0.996	0.000
M79.38 Panniculitis, unspecified (Other)	0.004	0.996	0.000
M79.37 Panniculitis, unspecified (Ankle and foot)	0.004	0.996	0.000
M79.36 Panniculitis, unspecified (Lower leg)	0.004	0.996	0.000
M79.35 Panniculitis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
M79.34 Panniculitis, unspecified (Hand)	0.004	0.996	0.000
M79.33 Panniculitis, unspecified (Forearm)	0.004	0.996	0.000
M79.32 Panniculitis, unspecified (Upper arm)	0.004	0.996	0.000
M79.31 Panniculitis, unspecified (Shoulder region)	0.004	0.996	0.000
M79.30 Panniculitis, unspecified (Multiple sites)	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
M79.99 Soft tissue disorder, unspecified (Site unspecified)	0.004	0.996	0.000
Y42.5 Other oestrogens and progestogens	0.004	0.996	0.000
Y54.4 Loop [high-ceiling] diuretics	0.004	0.996	0.000
Q27 Other congenital malformations of peripheral vascular system	0.004	0.996	0.000
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
M79.93 Soft tissue disorder, unspecified (Forearm)	0.004	0.996	0.000
M79.92 Soft tissue disorder, unspecified (Upper arm)	0.004	0.996	0.000
M79.91 Soft tissue disorder, unspecified (Shoulder region)	0.004	0.996	0.000
M79.90 Soft tissue disorder, unspecified (Multiple sites)	0.004	0.996	0.000
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
M79.80 Other specified soft tissue disorders (Multiple sites)	0.004	0.996	0.000
M79.59 Residual foreign body in soft tissue (Site unspecified)	0.004	0.996	0.000
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)	0.004	0.996	0.000
M79.53 Residual foreign body in soft tissue (Forearm)	0.004	0.996	0.000
M79.52 Residual foreign body in soft tissue (Upper arm)	0.004	0.996	0.000
M79.51 Residual foreign body in soft tissue (Shoulder region)	0.004	0.996	0.000
M79.50 Residual foreign body in soft tissue (Multiple sites)	0.004	0.996	0.000
H72.1 Attic perforation of tympanic membrane	0.000	0.996	0.004
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.004	0.996	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.996	0.000
Y40 Systemic antibiotics	0.004	0.996	0.000
M79.98 Soft tissue disorder, unspecified (Other)	0.004	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec	0.004	0.996	0.000
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)	0.004	0.996	0.000
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)	0.004	0.996	0.000
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)	0.004	0.996	0.000
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)	0.004	0.996	0.000
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)	0.004	0.996	0.000
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)	0.004	0.996	0.000
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)	0.004	0.996	0.000
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)	0.004	0.996	0.000
G50.1 Atypical facial pain	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
M79.26 Neuralgia and neuritis, unspecified (Lower leg)	0.004	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
M79.56 Residual foreign body in soft tissue (Lower leg)	0.004	0.996	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Q23 Congenital malformations of aortic and mitral valves	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
H61.2 Impacted cerumen	0.000	0.996	0.004
Y54.7 Agents affecting calcification	0.004	0.996	0.000
Q28 Other congenital malformations of circulatory system	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.004	0.996	0.000
Y45.8 Other analgesics and antipyretics	0.004	0.996	0.000
Y54.9 Mineral salts, not elsewhere classified	0.004	0.996	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.004	0.996	0.000
Y54.0 Mineralocorticoids	0.004	0.996	0.000
Q25 Congenital malformations of great arteries	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Q23.0 Congenital stenosis of aortic valve	0.004	0.996	0.000
N62 Hypertrophy of breast	0.000	0.996	0.004
Q28.2 Arteriovenous malformation of cerebral vessels	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
Y41.0 Sulphonamides	0.003	0.996	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.003	0.996	0.000
Y48.3 Local anaesthetics	0.003	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.996	0.000
H02.1 Ectropion of eyelid	0.000	0.996	0.004
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.996	0.000
G81.9 Hemiplegia, unspecified	0.000	0.997	0.003
Q25.4 Other congenital malformations of aorta	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)	0.003	0.997	0.000
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.003	0.997	0.000
L53.9 Erythematous condition, unspecified	0.000	0.997	0.003
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
H34 Retinal vascular occlusions	0.000	0.997	0.003
Q23.1 Congenital insufficiency of aortic valve	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Q27.4 Congenital phlebectasia	0.003	0.997	0.000
Q27.2 Other congenital malformations of renal artery	0.003	0.997	0.000
Q27.1 Congenital renal artery stenosis	0.003	0.997	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
Q61.3 Polycystic kidney, unspecified	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Q25.3 Stenosis of aorta	0.003	0.997	0.000
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
R74.8 Abnormal levels of other serum enzymes	0.000	0.997	0.003
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
M79.54 Residual foreign body in soft tissue (Hand)	0.003	0.997	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)	0.003	0.997	0.000
Q26 Congenital malformations of great veins	0.003	0.997	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.003	0.997	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.003	0.997	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.003	0.997	0.000
Q23.4 Hypoplastic left heart syndrome	0.003	0.997	0.000
Q23.3 Congenital mitral insufficiency	0.003	0.997	0.000
Q23.2 Congenital mitral stenosis	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Q28.3 Other malformations of cerebral vessels	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.003	0.997	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.003	0.997	0.000
Q28.1 Other malformations of precerebral vessels	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
R79.0 Abnormal level of blood mineral	0.000	0.997	0.003
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.003	0.997	0.000
Q25.8 Other congenital malformations of great arteries	0.003	0.997	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.003	0.997	0.000
Q25.5 Atresia of pulmonary artery	0.003	0.997	0.000
Q25.2 Atresia of aorta	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
Q25.0 Patent ductus arteriosus	0.003	0.997	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.003	0.997	0.000
H34.1 Central retinal artery occlusion	0.000	0.997	0.003
Q25.6 Stenosis of pulmonary artery	0.003	0.997	0.000
Q25.1 Coarctation of aorta	0.003	0.997	0.000
Q61 Cystic kidney disease	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
R72 Abnormality of white blood cells, not elsewhere classified	0.000	0.997	0.003
M79.83 Other specified soft tissue disorders (Forearm)	0.002	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
K46 Unspecified abdominal hernia	0.000	0.997	0.003
Y40.3 Macrolides	0.003	0.997	0.000
Q61.2 Polycystic kidney, adult type	0.003	0.997	0.000
H34.9 Retinal vascular occlusion, unspecified	0.000	0.997	0.003
H34.0 Transient retinal artery occlusion	0.000	0.997	0.003
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
Q07.0 Arnold-Chiari syndrome	0.003	0.997	0.000
R74 Abnormal serum enzyme levels	0.000	0.997	0.003
K70.3 Alcoholic cirrhosis of liver	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.997	0.003
Y46.7 Anti-Parkinsonism drugs	0.002	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
V10-V19 Pedal cyclist injured in transport accident	0.003	0.997	0.000
V11.4 Driver injured in traffic accident	0.003	0.997	0.000
Y60.0 During surgical operation	0.003	0.997	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.997	0.003
Y54.5 Other diuretics	0.002	0.997	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.003	0.997	0.000
Q24 Other congenital malformations of heart	0.002	0.997	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.003	0.997	0.000
I35.1 Aortic (valve) insufficiency	0.003	0.997	0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.002	0.997	0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.002	0.997	0.000
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.997	0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.002	0.997	0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.002	0.997	0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.002	0.997	0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.002	0.997	0.000
W50-W64 Exposure to animate mechanical forces	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
Y51.0 Anticholinesterase agents	0.002	0.997	0.000
H61 Other disorders of external ear	0.000	0.997	0.003
Y57.7 Vitamins, not elsewhere classified	0.002	0.997	0.000
Y57.4 Pharmaceutical excipients	0.002	0.997	0.000
Y57.3 Alcohol deterrents	0.002	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
Y57.1 Lipotropic drugs	0.002	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.997	0.000
D68.9 Coagulation defect, unspecified	0.000	0.997	0.003
W57.0 Home	0.002	0.997	0.000
Y57.6 Other diagnostic agents	0.002	0.997	0.000
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.002	0.997	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.002	0.997	0.000
Q20.6 Isomerism of atrial appendages	0.002	0.997	0.000
Q20.5 Discordant atrioventricular connexion	0.002	0.997	0.000
Q20.4 Double inlet ventricle	0.002	0.997	0.000
Q20.3 Discordant ventriculoarterial connexion	0.002	0.997	0.000
Q20.2 Double outlet left ventricle	0.002	0.997	0.000
Q20.1 Double outlet right ventricle	0.002	0.997	0.000
Q20.0 Common arterial trunk	0.002	0.997	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.002	0.997	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.002	0.997	0.000
Q22.6 Hypoplastic right heart syndrome	0.002	0.997	0.000
Q22.5 Ebstein's anomaly	0.002	0.997	0.000
Q22.4 Congenital tricuspid stenosis	0.002	0.997	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.002	0.997	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.002	0.997	0.000
Q22.1 Congenital pulmonary valve stenosis	0.002	0.997	0.000
Q22.0 Pulmonary valve atresia	0.002	0.997	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.002	0.997	0.000
Q26.8 Other congenital malformations of great veins	0.002	0.997	0.000
Q26.6 Portal vein-hepatic artery fistula	0.002	0.997	0.000
Q26.5 Anomalous portal venous connexion	0.002	0.997	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.002	0.997	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.002	0.997	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.002	0.997	0.000
Q26.1 Persistent left superior vena cava	0.002	0.997	0.000
Q26.0 Congenital stenosis of vena cava	0.002	0.997	0.000
Q07 Other congenital malformations of nervous system	0.002	0.997	0.000
W55 Bitten or struck by other mammals	0.002	0.997	0.000
V40-V49 Car occupant injured in transport accident	0.002	0.997	0.000
Q61.9 Cystic kidney disease, unspecified	0.002	0.998	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
Q60-Q64 Congenital malformations of the urinary system	0.002	0.998	0.000
H61.8 Other specified disorders of external ear	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations